Canada markets open in 20 minutes

  • S&P/TSX

    18,421.60
    +121.98 (+0.67%)
     

  • S&P 500

    3,870.29
    -31.53 (-0.81%)
     

  • DOW

    31,391.52
    -143.99 (-0.46%)
     

  • CAD/USD

    0.7910
    -0.0002 (-0.02%)
     

  • CRUDE OIL

    60.83
    +1.08 (+1.81%)
     

  • BTC-CAD

    64,767.62
    +2,504.75 (+4.02%)
     

  • CMC Crypto 200

    1,022.34
    +34.24 (+3.47%)
     

  • GOLD FUTURES

    1,709.60
    -24.00 (-1.38%)
     

  • RUSSELL 2000

    2,231.51
    -43.81 (-1.93%)
     

  • 10-Yr Bond

    1.4650
    +0.0500 (+3.53%)
     

  • NASDAQ futures

    12,984.50
    -70.75 (-0.54%)
     

  • VOLATILITY

    24.29
    +0.94 (+4.03%)
     

  • FTSE

    6,635.22
    +21.47 (+0.32%)
     

  • NIKKEI 225

    29,559.10
    +150.93 (+0.51%)
     

  • CAD/EUR

    0.6560
    +0.0015 (+0.23%)
     
MARKETS LIVE BLOG:

FUTURES JUMP AS STOCKS AIM FOR REBOUND

Mortgage applications increased only slightly last week as rates jumped

Eric Gordon with a deep 3 vs the Dallas Mavericks

Eric Gordon (Houston Rockets) with a deep 3 vs the Dallas Mavericks, 01/23/2021

Latest Stories

  • Rishi Sunak's Budget Explained In Two Minutes

    Furlough, Universal Credit, tax rises – here are the key announcements from the chancellor's speech.

  • HPCL Recruitment 2021: Applications for 200 engineer posts open at jobs.hpcl.co.in

    The last date to fill up the application form is 15 April. It will be a computer-based examination

  • UK's Sunak extends COVID rescue plan but companies to pay more tax from 2023

    Finance minister Rishi Sunak announced a costly extension of his emergency aid programmes to see Britain's economy through its current coronavirus lockdown, but announced a tax hike for many businesses as he began to focus on fixing the public finances. Delivering an annual budget speech on Wednesday, Sunak said the economy will regain its pre-pandemic size in the middle of 2022, six months earlier than previously forecast, helped by Europe's fastest COVID-19 vaccination programme. But it will remain 3% smaller in five years' time than it would have been without the damage wrought by the coronavirus crisis and extra support is needed now as the country remains under coronavirus restrictions, he said.

  • Britain's Sunak freezes personal tax thresholds until 2026

    Britain will freeze the amount of money that people can earn tax-free and also the threshold for the higher rate of income tax until 2026, finance minister Rishi Sunak said on Wednesday. Sunak said that while a basic income tax rate of 20% and a higher income tax rate 40% would not be increased, the thresholds for the "personal allowance" of tax-free earnings and at which the higher tax rate kicks in would not rise with inflation. Sunak said that the freeze was part of an approach to fix public finances as he looks for ways to raise funds following unprecedented measures to support jobs and the economy during the coronavirus pandemic.

  • ICC investigates alleged crimes in Palestinian territories

    The Prosecutor of the International Criminal Court said Wednesday she has launched an investigation into alleged crimes in the Palestinian territories. Fatou Bensouda said in a statement the probe will be conducted “independently, impartially and objectively, without fear or favor.” Bensouda said in 2019 there was a “reasonable basis” to open a war crimes probe into Israeli military actions in the Gaza Strip as well as Israeli settlement activity in the occupied West Bank.

  • Earthquake: 6.3-magnitude quake shakes central Greece, tremors felt in Balkans

    There were no immediate reports of injuries. Local officials reported some structural damage, mainly to old houses and buildings that saw walls collapse or crack

  • Bionano Customer Praxis Genomics Receives DEX Z-Codes from Palmetto for their Whole Genome Analysis LDT on Saphyr

    SAN DIEGO, March 03, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that Praxis Genomics, LLC received DEX Z-codes from Palmetto MolDX for its entire testing menu of laboratory developed tests (LDTs) based on Saphyr. The DEX Z-Code modifier is a unique 5-character alpha-numeric code associated with certain molecular diagnostics tests and is typically used by certain payers as an adjunct to non-specific CPT codes when no specific CPT code applies. The code, submitted on a claim along with a particular CPT code provides greater clarity to help payers and physicians understand which test is being ordered, performed and billed. The process removes the need for the provider to submit large amounts of additional information with every claim and can expedite claim payment. The assignment of DEX Z-codes to Praxis’s menu of Saphyr-based LDTs is potentially a major step forward in the coding and eventual coverage of Saphyr-based tests. Praxis is the first CAP-accredited, CLIA-certified diagnostic lab in the United States to develop and offer commercially an LDT based on whole genome analysis with Saphyr. Praxis uses optical genome mapping (OGM) as an alternative to traditional methods of chromosomal microarray (CMA) and karyotyping (KT), as they seek to improve the rate of clinical diagnosis for patients with genetic disease. The Z-codes allow for a path for Medicare coverage and private insurance reimbursement for OGM with Saphyr of patients with suspected genetic disease. The Saphyr system is capable of handling Praxis’ sample workload after the latest updates to the system enabled it to map 96 human samples per week, or about 5,000 per year. Bionano continues to focus on improving the throughput of OGM for even higher volume laboratories and aims to increase the throughput of a single system to as much as 17,000 samples per year by the first half of 2023, while reducing the consumables cost to a target price of $100 per sample. “We are impressed with the progress of Praxis Genomics and its founder Dr. Peter L. Nagy towards making OGM a first line test for genetic disease genome analysis,” commented Erik Holmlin, PhD, CEO of Bionano Genomics. “Following Praxis’ CAP accreditation, we believe that the assignment of MolDX Z-codes for Saphyr testing is an important next step to enable more widespread reimbursement of OGM by private and public payers. Praxis once again is the first U.S. laboratory to pass this milestone, and we believe other U.S. labs will follow in Praxis’ footsteps over time and build the path towards reimbursement. Bionano continues to invest in making OGM faster and even more cost effective to make it the cytogenomics solution suiting the full range of testing volumes, from small, local cytogenetics labs to high-volume commercial or academic testing sites.” About Bionano GenomicsBionano is a genome analysis company providing tools and services based on its Saphyr system to scientists and clinicians conducting genetic research and patient testing, and providing diagnostic testing for those with autism spectrum disorder (ASD) and other neurodevelopmental disabilities through its Lineagen business. Bionano’s Saphyr system is a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes, which is known as cytogenetics. The Saphyr system is comprised of an instrument, chip consumables, reagents and a suite of data analysis tools, and genome analysis services to provide access to data generated by the Saphyr system for researchers who prefer not to adopt the Saphyr system in their labs. Lineagen has been providing genetic testing services to families and their healthcare providers for over nine years and has performed over 65,000 tests for those with neurodevelopmental concerns. For more information, visit www.bionanogenomics.com or www.lineagen.com. Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “may,” “will,” “expect,” “plan,” “anticipate,” “estimate,” “intend” and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) convey uncertainty of future events or outcomes and are intended to identify these forward-looking statements. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses or current expectations concerning, among other things: our expectations regarding potential reimbursement of Praxis’ menu of Saphyr-based LDTs; the capability of Praxis’ menu of Saphyr-based LDTs to replace the tiered approach recommended by medical guidelines and to become a first line test for genetic disease genome analysis; our expectations regarding future reimbursement potential for Saphyr-based LDTs by third party payors; Saphyr’s potential as a powerful new tool in cytogenetics and its potential contribution to improvements in traditional cytogenetics; Praxis Genomics’ intended use of the Saphyr system and our services, including to demonstrate Saphyr’s capabilities in comparison to NGS; the ability to integrate data from the Saphyr system into other offerings by Praxis Genomics; our expectations regarding further widespread adoption and utilization of the Saphyr system for various clinical applications; improvements in patient outcomes driven by increased use of Saphyr-based tests in the LDT arena; and our strategic plans. Each of these forward-looking statements involves risks and uncertainties. Actual results or developments may differ materially from those projected or implied in these forward-looking statements. Factors that may cause such a difference include the risks and uncertainties associated with: the impact of the COVID-19 pandemic on our business and the global economy; general market conditions; changes in the competitive landscape and the introduction of competitive products; changes in our strategic and commercial plans; our ability to obtain sufficient financing to fund our strategic plans and commercialization efforts; the loss of key members of management and our commercial team; and the risks and uncertainties associated with our business and financial condition in general, including the risks and uncertainties described in our filings with the Securities and Exchange Commission, including, without limitation, our Annual Report on Form 10-K for the year ended December 31, 2019 and in other filings subsequently made by us with the Securities and Exchange Commission. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management's assumptions and estimates as of such date. We do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise. CONTACTSCompany Contact:Erik Holmlin, CEOBionano Genomics, Inc.+1 (858) 888-7610eholmlin@bionanogenomics.com Investor Relations Contact:Ashley R. RobinsonLifeSci Advisors, LLC+1 (617) 430-7577arr@lifesciadvisors.com Media Contact:Darren Opland, PhDLifeSci Communications+1 (617) 733-7668darren@lifescicomms.com

  • Camilla says hospitalized Prince Philip is 'slightly' better

    Prince Philip is “slightly improving” and the royal family is keeping its fingers crossed for the hospitalized duke's recovery, his daughter-in-law Camilla, Duchess of Cornwall, said Wednesday. Philip, 99, has been hospitalized since being admitted Feb. 16 to King Edward VII’s Hospital in London, where he was treated for an infection. Camilla said during a visit to a coronavirus vaccination center in London that Philip is “slightly improving,” but he “hurts at moments.”

  • Ant Middleton: Former SAS star says 'woke patrol took over series

    On Tuesday, Channel 4 said it would not work with Middleton again due to his "personal conduct".

  • Budget 2021: 10 ways Rishi Sunak's speech affects you

    Chancellor Rishi Sunak's Budget is packed with policies that will affect your finances. Here is a guide.

  • When does the stamp duty holiday in England and Northern Ireland end?

    The chancellor has announced an extension to the stamp duty holiday?

  • COVAXIN shows interim efficacy of 81% against coronavirus in Phase 3 clinical trials, says Bharat Biotech

    The first interim analysis is based on 43 cases, of which 36 cases of COVID-19 were observed in the placebo group versus seven cases observed in the BBV152 (Covaxin) group, the company said

  • Lockdown With My Teen Made Me Fall In Love With Music Again

    There’s no rift a great song can’t heal.

  • West Bengal Assembly election 2021, English Bazaar profile: Independent candidate Nihar Ranjan Ghosh won seat in 2016

    The English Bazar Assembly constituency is expected to go to polls in April-May 2021, as part of West Bengal Assembly election 2021.

  • Good Luck Betting Against fuboTV Stock

    The market wasn't blown away by the sports-first live TV streaming service in its second quarterly earnings release since going public. Don't fumble this opportunity.

  • Ceapro Inc. to Present at the H.C. Wainwright Global Life Sciences Conference

    EDMONTON, Alberta, March 03, 2021 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced today that Gilles Gagnon, President and Chief Executive Officer of Ceapro will present at the virtual H.C. Wainwright Global Life Sciences Conference taking place March 9-10, 2021. In addition to the presentation, management will also be available to participate in virtual one-on-one meetings with qualified members of the investor community who are registered to attend the conference. For more information about the conference, please visit the conference website here. The video webcast presentation will be available for viewing on-demand beginning Tuesday, March 9, 2021, at 7:00 AM ET for those registered for the event and will be accessible on the IR Calendar page of the Investors section of the Company's website (www.ceapro.com) and will be archived for 90 days following the event. About Ceapro Inc. Ceapro Inc. is a Canadian biotechnology company involved in the development of proprietary extraction technology and the application of this technology to the production of extracts and “active ingredients” from oats and other renewable plant resources. Ceapro adds further value to its extracts by supporting their use in cosmeceutical, nutraceutical, and therapeutics products for humans and animals. The Company has a broad range of expertise in natural product chemistry, microbiology, biochemistry, immunology and process engineering. These skills merge in the fields of active ingredients, biopharmaceuticals and drug-delivery solutions. For more information on Ceapro, please visit the Company’s website at www.ceapro.com. For more information contact: Jenene ThomasJTC Team, LLCInvestor Relations and Corporate Communications AdvisorT (US): +1 (833) 475-8247E: czo@jtcir.com Issuer: Gilles R. Gagnon, M.Sc., MBAPresident & CEOT: 780-421-4555 Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release

  • Retail Analytics Market to Reach $23.8 billion by 2027- Exclusive Report Covering Pre and Post COVID-19 Market Analysis and Forecasts by Meticulous Research®

    Retail Analytics Market by Component (Software, Services), Organization Size, Application (Finance Management, Marketing, Price Optimization, Human Resource Management, Operations Management), And Region – Global Forecast to 2027London, March 03, 2021 (GLOBE NEWSWIRE) -- According to a new market research report titled, “Retail Analytics Market by Component (Software, Services), Organization Size, and Application (Finance Management, Marketing, Price Optimization, Human Resource Management, Operations Management)– Global Forecast to 2027”, the retail analytics market is expected to grow at a CAGR of 19.1% from 2020 to 2027 to reach $23.8 billion by 2027.Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5175 Retail analytics refers to the process of offering analytical data on sales, consumer demand, inventory levels, and supply chain operations, among others. The analytics software helps users understand and interpret insights based on huge data generated from various devices, tools, and platforms allocated in the retail shops. The rising adoption of disruptive technologies primarily drives the retail analytics market to forecast future market trends, growing significance for enhancement of customer experiences and retail operations, and increasing use of m-commerce. However, lack of technology adoption by the unorganized retail sector and legal concerns & data privacy issues are hindering the market growth. The growing adoption of cloud services in retail and the advent of computer vision are the latest trends contributing to the growth of the retail analytics market. Impact of COVID-19 on the Retail Analytics Market The COVID-19 pandemic has adversely hit many economies around the globe. However, the market for technology in the data analytics sector was not affected to a greater extent. As a result, the retail analytics market is projected to witness fast recovery post-COVID-19 pandemic. Lockdowns and quarantine to counter COVID-19 have restricted the companies' physical access to operate with the existing resources. This triggered the adoption rate of retail analytics solutions and services. Moreover, amidst the pandemic, high use of retail analytics was witnessed among various retailers for visualizing and interpreting the impacts of the pandemic. A shift to e-commerce and contact-less delivery options significantly changed consumer behavior, making a new retail ecosystem. The consumer preferences were mainly focused on proactive health-oriented buying, pantry stockpiling, and daily use essentials. Speak to our Analysts to Understand the Impact of COVID-19 on Your Business: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5175 The retail analytics market is segmented based on component, organization size, application, and geography. The study also evaluates industry competitors and analyzes the market at the country level. Based on component, the retail analytics market is segmented into software and services. In 2020, the software segment commanded the largest share of the overall retail analytics market. The largest share of this segment is mainly attributed to the growth in software adoption for analyzing customer buying preferences to formulate business strategies. Based on application, the retail analytics market is segmented into finance, marketing and price optimization, human resources, operations, and other applications. In 2020, the marketing and price optimization segment commanded the largest share of the overall retail analytics market. The large share of this segment is attributed to the growing need of businesses to adopt predictive analytics strategies that enhance sales. Based on organization size, the market is segmented into large and small enterprises. In 2020, the large enterprises segment accounted for the largest share of the overall retail analytics market. The SMEs segment is expected to witness the fastest growth over the coming years, mainly attributed to the increasing adoption of cloud-based services. Quick Buy – Retail Analytics Market Research Report: https://www.meticulousresearch.com/Checkout/63810475 Geographically, in 2020, North America commanded the largest share of the global retail analytics market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The rising demand for customized retail analytics solutions to predict and understand customer insights and increasing adoption of retail analytics to improvise business processes are expected to drive the market growth for the North American region. However, Asia-Pacific region is expected to witness rapid growth during the forecast period. The report also includes an extensive assessment of the key strategic developments adopted by the leading market participants in the industry over the past three years. The retail analytics market has witnessed several agreements, collaborations, and partnerships in recent years. The retail analytics market is consolidated and dominated by few major players, namely Microsoft Corporation (U.S.), IBM Corporation (U.S.), Salesforce.com, Inc. (U.S.), SAP SE (Germany), HCL Technologies Limited (India), SAS Institute, Inc. (U.S.), Qlik (U.S.), Manthan Software Services Pvt. Ltd. (India), BRIDGEi2i Analytics Solutions (India), MicroStrategy Incorporated (U.S.), Teradata (U.S.), Amazon Web Services (U.S.), Fujitsu (Japan), Oracle Corporation (U.S.), Domo, Inc. (U.S.), and Tableau Software, Inc. (U.S.) among others. To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/retail-analytics-market-5175 Scope of the report Retail Analytics Market, by Component Software Business IntelligenceSales ForecastingDemand ForecastingOthers Services Professional ServicesManaged Services Retail Analytics Market, by Organization Size Large Enterprises Small & Medium-sized Enterprises Retail Analytics Market, by Application Finance PoS ManagementPayment Management Marketing and Price Optimization Merchandising AnalyticsPromotional Analysis & PlanningPricing AnalyticsCatalog Management Human Resources Operations Digital Supply Chain AnalyticsInventory AnalyticsCustomer AnalyticsOrder Management Retail Analytics Market, by Geography North America U.S.Canada Europe GermanyU.K.FranceItalySpainRest of Europe Asia-Pacific JapanChinaIndia Rest of Asia-Pacific Latin AmericaMiddle East & Africa Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5175 Amidst this crisis, Meticulous Research® is continuously assessing the impact of the COVID-19 pandemic on various sub-markets and enables global organizations to strategize for the post-COVID-19 world and sustain their growth. Let us know if you would like to assess the impact of COVID-19 on any industry here- https://www.meticulousresearch.com/custom-research Related Reports: Artificial Intelligence in Retail Market by Product, Application (Predictive Merchandizing, Programmatic Advertising), Technology (Machine Learning, Natural Language Processing), Deployment (Cloud, On-Premises), and Geography - Global Forecast to 2027 https://www.meticulousresearch.com/product/artificial-intelligence-in-retail-market-4979 Location Analytics Market by Component, Location, Application (Risk Management, Supply Chain Optimization, and Customer Management), End-use Industry (Smart Cities, Healthcare, Retail, Government, Logistics, Utilities), and Region - Forecast to 2027 https://www.meticulousresearch.com/product/location-analytics-market-5150 Document Analytics Market by Product Type (Solution and Services), Deployment Type, Industry Vertical (BFSI, Government, Healthcare, Retail and ecommerce, Manufacturing, Transportation), Organization Size, and Region - Global Forecast to 2027 https://www.meticulousresearch.com/product/document-analytics-market-5140 Digital Transformation Market by Technology (IoT, Cloud Computing, Big Data Analytics, Artificial Intelligence, Cybersecurity), End-use Industry (Retail, Government and Public Sector, Healthcare, Supply Chain and Logistics, Utilities, Manufacturing, Insurance, IT and Telecom, Media and Entertainment) Industry Size, Process (Customer Transformation, Operational Transformation) - Global Forecast to 2025https://www.meticulousresearch.com/product/digital-transformation-market-4980/ About Meticulous Research® Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze and present the critical market data with great attention to detail. With meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth. Contact:Mr. Khushal BombeMeticulous Research®Direct Lines: +1-646-781-8004 (North America)+44-203-868-8738 (Europe)+91 744-7780008 (Asia-Pacific)Email- sales@meticulousresearch.comVisit Our Website: https://www.meticulousresearch.com/Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-researchContent Source: https://www.meticulousresearch.com/pressrelease/392/retail-analytics-market-2027 CONTACT: Mr. Khushal Bombe Meticulous Research® Direct Lines: +1-646-781-8004 (North America) Email- sales@meticulousresearch.com

  • Google vows no new user tracking in Chrome ad data changes

    Google says it won't develop new ways to follow individual users across the internet after it phases out existing ad tracking technology from Chrome browsers in an upcoming overhaul aimed at tightening up privacy. The digital giant has been working on proposals to remove from Chrome so-called third party cookies, which are snippets of code used by a website's advertisers to record browsing history in order to show users personalized ads. Third-party cookies have been a longstanding source of privacy concerns, so Google proposes instead grouping together web users with similar interests and keeping web histories private on user devices.

  • Michelle Obama reflects on 'glorious' inauguration mixed with concern 'about more riots'

    To Michelle Obama, President Joe Biden's inauguration was a "glorious day" mixed with concerns about more violence after the Jan. 6 U.S. Capitol riot.

  • Elder dissatisfied with service

    Elder Mabel Clarke, who lives at Birdtail Sioux Dakota Nation, wants her front door fixed. She said there are more elders on the reserve who have similar complaints. Clarke had a list of issues she said are not being dealt with: duplexes that do not have back doors, and therefore no emergency exit in case of fire, and elders are not receiving their home visits from nurses. "The chief and the nurses don’t look at us. I gathered all the elders to have a meeting. I told the chief, and he pushed us away about four times," said Clarke. "And the nurses never come to see the elders. They phone the health office and there’s never anybody there. I’m not the only one saying that. There’s a few other ladies that were saying that." On the list of repairs needed, Clarke includes doors needing repairs and some houses need ramps. "We have to hang blankets on our doors," she said. The Brandon Sun spoke to Chief Ken Chalmers on Tuesday. He addressed each concern, while noting 14 major renovations are currently occupying all available contractors. In five years, he has spent $5 million on homes on the reserve. Every penny and house number is recorded with the Canada Mortgage and Housing Corporation (CMHC) or with Indigenous Services Canada (ISC), who provide funding for houses and house repairs. On the matter of meeting with the elders, he cited COVID-19 concerns. A meeting would have meant almost 30 people gathered indoors, which would have contravened pandemic-related provincial public health orders and created a super-spreading event As for Clarke’s house, Chalmers said that’s a far more complicated matter. Her home was fully renovated three and a half years ago to the tune of almost $50,000, but Clarke’s grandson went on a rampage, kicking in the doors and breaking the windows. Chalmers said that’s a regular occurrence. One year, Clarke’s grandson not only kicked in the doors and broke windows, but also destroyed a wall, "electrical wires hanging down and everything." One year, Clarke’s grandson also burned down the reserve church and went to jail for it. Each time, Chalmers said, repairs have been done to Clarke’s home. He said he has all the records, and he figures he has spent $100,000 to $120,000 repairing the house that, in 2018, was in excellent condition. "Every time, we fix it all up," said Chalmers. Chief and council passed a resolution to banish the grandson from the reserve, but he can’t actually be removed unless Clarke presses charges. Chalmers said other family members have tried to get her to press charges. "She’s a nice, nice lady, but she has to press charges on this guy. She refuses," said Chalmers. "She lets him back in. Unconditional love." Chalmers describes a man who drinks, is addicted to methamphetamine, is violent and causes a lot of trouble. "And she’s taking the brunt of it," he said. Chalmers also said others on the reserve are getting tired of it, because some also need home repairs. Nevertheless, he said her home would be repaired. He has to find the money for it, but he won’t get it from CMHC or Indigenous Services. "They’ll just outright refuse," he said. Chalmers did say that once the 14 major projects are completed, his crew would turn to other smaller repairs. As for the duplexes — they have windows meant to serve as fire exits. Chalmers said all building blueprints have to be approved before a build begins, and the buildings are fully inspected by an outside inspector. There is an entire process for that, which is tied to the funding. When it comes to ramps, there is also a process. To begin with, a band member must qualify for a ramp for health reasons. The band has put in temporary emergency ramps until funding can be acquired from Health Canada to build a permanent one. "We’ve been building those like crazy. We’re only allowed one or two ramps a year, but we usually build them ourselves. We built many this year already," said Chalmers. "People call us — we need a ramp here, we need a ramp there. But they need a doctor’s note. There’s special funding for that. I just gotta know where you need a ramp and I’ll put it up." Finally, home visits by nurses — Chalmers did not know what was going on with that. He leaves the health department to do its thing. He said it was the first he had heard of issues. Chalmers, who was in Brandon for a meeting, suggested the Sun call the health centre and speak with the health director to find out what might be going on with home visits. He suggested it might be related to the pandemic. The Sun did call, but there was no answer. Michèle LeTourneau, Local Journalism Initiative Reporter, Brandon Sun